Evidence map›Paper›PMID 42128944›Full record

ArticleEuropean radiology2026

CT-guided injection in coccydynia: outcome prediction using MRI findings and CT-injection characteristics.

Georg Wilhelm Kajdi, Thomas Marth, Christoph Germann, Mazda Farshad, Reto Sutter

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georg Wilhelm KajdiDepartment of Radiology, Balgrist University Hospital, Faculty of Medicine, University of Zurich, Zurich, Switzerland. georg.kajdi@balgrist.ch.ORCID http://orcid.org/0009-0002-3814-7633
Thomas MarthDepartment of Radiology, Balgrist University Hospital, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Christoph GermannDepartment of Radiology, Balgrist University Hospital, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Mazda FarshadDepartment of Orthopedics, Balgrist University Hospital, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Reto SutterDepartment of Radiology, Balgrist University Hospital, Faculty of Medicine, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo analyze pain relief for chronic coccydynia after CT-guided, pericoccygeal ropivacaine and triamcinolone injection over time and to investigate possible imaging predictors of successful and maintained pain relief. MATERIALS AND

methodsIn this retrospective study, chronic coccydynia patients receiving CT-guided pericoccygeal injections with ropivacaine and triamcinolone were assessed for pain relief post-injection, using a numeric rating scale (NRS, 0-10) and percentage pain reduction (PPR, %). Patients were followed up until pain recurrence. Two radiologists assessed MRI findings prior to, and contrast distribution during CT injection. Imaging predictors for successful pain relief at 1 month (PPR ≥ 50%) combined with maintained pain relief for at least 3 months post-injection were investigated using logistic regression analysis.

results63 patients (mean age 44.6 ± 12.5 years) were evaluated. Average pain dropped from initially 6.3 to 3.0 (average PPR 53.2 ± 37.5%) 15 min post-injection, and to 2.9 (average PPR 55.2 ± 41.4%) one month post-injection (all p < 0.001). One month post-injection, 41 patients (65%) reported PPR ≥ 50%. Pain relief persisted on average for 6 months. Three months post-injection, 32/63 patients (50.8%) reported maintained pain relief. Fluid-sensitive sequence (FSS)-hyperintensity of the sacro-/intercoccygeal synchondrosis, coccyx subluxation and a bony spicule were the only significant predictors (odds ratios: 3.5-5.1) of successful and maintained pain relief (all p ≤ 0.031).

conclusionCT-guided pericoccygeal injection with ropivacaine and triamcinolone allowed successful pain relief in 65% of chronic coccydynia patients, with a PPR of 55% and persistence of 26 weeks on average. Odds of successful and maintained pain relief increased with the presence of a bony spicule, subluxation and FSS-hyperintensity of the synchondrosis. KEY POINTS: Question Imaging predictors of successful pain relief in chronic coccydynia patients receiving pericoccygeal ropivacaine and triamcinolone injections are unknown. Findings A bony spicule, subluxation, and sacro-/intercoccygeal fluid-sensitive sequence hyperintensity on MRI were significant predictors of successful pain relief for ≥ 3 months. CT-contrast distribution did not influence pain relief. Clinical relevance CT-guided pericoccygeal injections with ropivacaine and triamcinolone offer successful pain relief in chronic coccydynia; the presence of a bony spicule, subluxation, and sacro-/intercoccygeal fluid-sensitive sequence hyperintensity was predictive of pain relief.

Indexed as

AmidesCoccyxLow Back PainMagnetic Resonance ImagingRadiography, InterventionalTomography, X-Ray ComputedTriamcinoloneAdultAnesthetics, LocalFemaleHumansMaleMiddle AgedPain MeasurementRetrospective StudiesRopivacaineAmidesAnesthetics, LocalRopivacaineTriamcinoloneCoccydyniaCoccyxCTMRIPain assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.